Rilpivirine long-acting (RPV-LA)

rilpivirine · Janssen Pharmaceuticals (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rilpivirine long-acting (RPV-LA), covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA) [Phase 4]

See pricing